These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3865895)

  • 1. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
    Kelly H; McCann VJ; Kay PH; Dawkins RL
    Immunogenetics; 1985; 22(6):643-51. PubMed ID: 3865895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrogastric autoimmunity and MHC associated alleles at the C4 locus in patients with type 1 (insulin-dependent) diabetes.
    McCann VJ; McCluskey J; Kelly H; Kay PH; Zilko PJ; Christiansen FT; Dawkins RL
    Diabetologia; 1984 Jul; 27 Suppl():124-5. PubMed ID: 6332753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes.
    Garlepp MJ; Wilton AN; Dawkins RL; White PC
    Immunogenetics; 1986; 23(2):100-5. PubMed ID: 3007340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes.
    Rich SS; Weitkamp LR; Barbosa J
    Am J Hum Genet; 1984 Sep; 36(5):1015-23. PubMed ID: 6594040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class III gene rearrangements in Thai/Chinese supratypes containing null or defective C4 alleles.
    Kay PH; Martin E; Dawkins RL; Charoenwong P
    Immunogenetics; 1988; 27(1):46-50. PubMed ID: 3334723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes.
    Deschamps I; Marcelli-Barge A; Lallemand N; Poirier JC; Bochu V; Prévost P; Busson A; Massét M; Lestradet H; Hors J
    Tissue Antigens; 1988 May; 31(5):259-69. PubMed ID: 3400091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A; Ohayon E; Hauptmann G; Sevin A; Abbal M; Sommer E; Vergnes H; Ducos J
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.
    McCluskey J; McCann VJ; Kay PH; Zilko PJ; Christiansen FT; O'Neill GJ; Dawkins RL
    Diabetologia; 1983 Mar; 24(3):162-5. PubMed ID: 6573286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family studies of IgA deficiency.
    Wilton AN; Cobain TJ; Dawkins RL
    Immunogenetics; 1985; 21(4):333-42. PubMed ID: 3997207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study.
    de Jongh BM; Bruining GJ; Schreuder GM; Schuurman RK; Radder JK; van Loghem E; Meera Khan P; Hauptmann G; van Rood JJ
    Hum Immunol; 1984 May; 10(1):5-21. PubMed ID: 6586708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC supratypes as markers of null and defective C4 alleles in a Thai/Chinese population: relevance to disease susceptibility.
    Kay PH; Grimsley G; Dawkins RL; Charoenwong P
    Dis Markers; 1987 Mar; 5(1):43-7. PubMed ID: 3502980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age of onset in vitiligo: relationship with HLA supratypes.
    Finco O; Cuccia M; Martinetti M; Ruberto G; Orecchia G; Rabbiosi G
    Clin Genet; 1991 Jan; 39(1):48-54. PubMed ID: 1997215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HLA, A, B, C, DR, C4, Bf in insulin-dependent diabetics in the Tunisian population].
    Jenhani F; Bardi R; Gorgi Y; Ayed K; Chammaki S; Boukhris R
    Ann Biol Clin (Paris); 1989; 47(1):23-8. PubMed ID: 2648900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Order of class III genes relative to HLA genes determined by the haplotype method.
    Wilton AN; Charlton B
    Immunogenetics; 1986; 24(2):79-83. PubMed ID: 3462127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphism of C4 and factor B in type I diabetes].
    Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M
    Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.
    Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J
    Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.